Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Interference With TNFα Using Long-Term Etanercept In S+S Antilles Sickle Transgenic Mice Ameliorates Abnormal Endothelial Activation, Vasoocclusion, and Pulmonary Hypertension Including Its Pulmonary Arterial Wall Remodeling

Anna Solovey, Arif Somani, Chunsheng Chen, James Kiley, Paul Marker, Fuad Abdulla, M Gerard O'Sullivan, Robert J Kelm, Jr., John D Belcher, Ph.D., Gregory M Vercellotti, Robert P Hebbel

Blood (2013) 122 (21): 728.

https://doi.org/10.1182/blood.V122.21.728.728

Published: 2013

Journal Articles

The Blood Monocyte - TNF - Endothelial Axis in Activation of Endothelial Tissue Factor in the Transgenic Sickle Mouse: Possible Relevance of Etanercept to Sickle Coagulopathy

Anna Solovey, M.D., Liming Milbauer Chang, Ph.D., Fuad Abdulla, Rahn Kollander, Paul H Marker, MS, Robert Kelm, Jr., Ph.D., Gregory M Vercellotti, MD, Robert P Hebbel, MD

Blood (2011) 118 (21): 1048.

https://doi.org/10.1182/blood.V118.21.1048.1048

Published: 2011

Journal Articles

The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease.

Robert P Hebbel, MD, Gregory M. Vercellotti, MD, Betty Pace, MD, Anna Solovey, M.D., Rahn Kollander, Chine Abanonu, Julia Nguyen, BS, Julie V. Vineyard, BS, John D Belcher, Ph.D., Fuad Abdulla, Shade Osifuye, John W. Eaton, PhD, Robert Kelm, MD, Arne Slungaard, MD

Blood (2009) 114 (22): 2586.

https://doi.org/10.1182/blood.V114.22.2586.2586

Published: 2009

Journal Articles

Therapeutic Inhibition of Endothelial Cell Tissue Factor Expression In Vivo by Nitric Oxide and Arginine in Sickle Transgenic Mice.

Robert P. Hebbel, MD, Rahn Kollander, Anna Solovey, PhD, Stephana Choong, PhD, Robert J. Kelm, Jr., PhD

Blood (2005) 106 (11): 210.

https://doi.org/10.1182/blood.V106.11.210.210

Published: 2005

Journal Articles

Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin

Anna Solovey, Rahn Kollander, Arun Shet, Liming C. Milbauer, Stephana Choong, Angela Panoskaltsis-Mortari, Bruce R. Blazar, Robert J. Kelm, Jr, Robert P. Hebbel

Blood (2004) 104 (3): 840–846.

https://doi.org/10.1182/blood-2003-10-3719

Published: 2004

Journal Articles

Use of blood outgrowth endothelial cells for gene therapy for hemophilia A

Yi Lin, Liming Chang, Anna Solovey, John F. Healey, Pete Lollar, Robert P. Hebbel

Blood (2002) 99 (2): 457–462.

https://doi.org/10.1182/blood.V99.2.457

Published: 2002

Journal Articles

Sickle Cell Anemia as a Possible State of Enhanced Anti-Apoptotic Tone: Survival Effect of Vascular Endothelial Growth Factor on Circulating and Unanchored Endothelial Cells

Anna Solovey, Lizhen Gui, Sundaram Ramakrishnan, Martin H. Steinberg, Robert P. Hebbel

Blood (1999) 93 (11): 3824–3830.

https://doi.org/10.1182/blood.V93.11.3824

Published: 1999

NARROW

Interference With TNFα Using Long-Term Etanercept In S+S Antilles Sickle Transgenic Mice Ameliorates Abnormal Endothelial Activation, Vasoocclusion, and Pulmonary Hypertension Including Its Pulmonary Arterial Wall Remodeling

The Blood Monocyte - TNF - Endothelial Axis in Activation of Endothelial Tissue Factor in the Transgenic Sickle Mouse: Possible Relevance of Etanercept to Sickle Coagulopathy

The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease.

Therapeutic Inhibition of Endothelial Cell Tissue Factor Expression In Vivo by Nitric Oxide and Arginine in Sickle Transgenic Mice.

Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin

Use of blood outgrowth endothelial cells for gene therapy for hemophilia A

Sickle Cell Anemia as a Possible State of Enhanced Anti-Apoptotic Tone: Survival Effect of Vascular Endothelial Growth Factor on Circulating and Unanchored Endothelial Cells

Email alerts

ASH Publications

American Society of Hematology

Interference With TNFα Using Long-Term Etanercept In S+S Antilles Sickle Transgenic Mice Ameliorates Abnormal Endothelial Activation, Vasoocclusion, and Pulmonary Hypertension Including Its Pulmonary Arterial Wall Remodeling

The Blood Monocyte - TNF - Endothelial Axis in Activation of Endothelial Tissue Factor in the Transgenic Sickle Mouse: Possible Relevance of Etanercept to Sickle Coagulopathy

The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease.

Therapeutic Inhibition of Endothelial Cell Tissue Factor Expression In Vivo by Nitric Oxide and Arginine in Sickle Transgenic Mice.

Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin

Use of blood outgrowth endothelial cells for gene therapy for hemophilia A

Sickle Cell Anemia as a Possible State of Enhanced Anti-Apoptotic Tone: Survival Effect of Vascular Endothelial Growth Factor on Circulating and Unanchored Endothelial Cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only